U.S. to consider expanding Medicare drug price negotiation

WASHINGTON (Reuters) – The Trump administration is considering expanding Medicare’s ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines administered in hospitals and doctors’ offices, Health and Human Services Secretary Alex Azar said on Monday.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *